tradingkey.logo
tradingkey.logo
Search

Rainier Acquisition Units

RNAQU
Add to Watchlist
10.000
0.000--
Close 11-13 16:00(ET)
--Market Cap
--P/E TTM

About Rainier Acquisition Units Company

Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.

Rainier Acquisition Units Profile

Ticker SymbolRNAQU
Company nameRainier Acquisition Corp
IPO dateAug 27, 2026
CEO- -
Number of employees- -
Security typeUnit
Fiscal year-endAug 27
Address1 Penn Plaza, 48th floor
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10119
Phone16464659000
Website
Ticker SymbolRNAQU
IPO dateAug 27, 2026
CEO- -

Company Executives of Rainier Acquisition Units

Name
Name/Position
Position
Shareholding
Change
Mr. Jonas Grossman
Mr. Jonas Grossman
Director
Director
194.38K
--
Mr. Jonas Grossman
Mr. Jonas Grossman
Director
Director
194.38K
--
Mr. Jonas Grossman
Mr. Jonas Grossman
Director
Director
194.38K
--
Mr. Chidozie Ugwumba
Mr. Chidozie Ugwumba
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Gbola Amusa, M.D.
Dr. Gbola Amusa, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Andrew Lam, Ph.D.
Dr. Andrew Lam, Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Isaac Manke, Ph.D.
Dr. Isaac Manke, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Guy Barudin
Mr. Guy Barudin
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gbola Amusa, M.D.
Dr. Gbola Amusa, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
,
,
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jonas Grossman
Mr. Jonas Grossman
Director
Director
194.38K
--
Mr. Jonas Grossman
Mr. Jonas Grossman
Director
Director
194.38K
--
Mr. Jonas Grossman
Mr. Jonas Grossman
Director
Director
194.38K
--
Mr. Chidozie Ugwumba
Mr. Chidozie Ugwumba
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Gbola Amusa, M.D.
Dr. Gbola Amusa, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Andrew Lam, Ph.D.
Dr. Andrew Lam, Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.